Gen pharma share price target 2022 On November 16, 1992, the corporation was established as a public limited company under the Companies Act, 1956 in the state of Gujarat as “AdiRasayan Limited.” On November 20, 1992, the company received a Certificate of Incorporation from the ROC of Gujarat. On April 10, 2019, the Company’s Registered Office was relocated from the state of Gujarat to the state of Maharashtra in Mumbai. On November 27, 2018, the name of the company was changed from “AdiRasayan Limited” to “GENERIC PHARMASEC LIMITED.”
Gen pharma share price target 2022, 2023, 2024, 2025
The company’s current name is “GENPHARMASEC LIMITED.” On October 25, 2021, a new certificate of incorporation was received from the Registrar of Companies, Maharashtra in Mumbai as a result of the name change.
Generic Pharmasec Limited, founded in 1992, began as a manufacturer and trader of various chemicals, dyes, and pigments. In 2018, the Company expanded its operations to include the purchase, sale, and distribution of pharmaceutical, medicinal and medicated preparations, as well as a venture into the securities market. In 2019, the firm chose to refocus its efforts on the lucrative medical and diagnostics device market. Abbott Point of Care Corporation INC has joined forces with the firm.
Gen pharma share price target 2023 The USA for the marketing of unique specialist diagnostic equipment, especially the i-STAT 1 Analyzer, a palm blood analyzer that is only utilized in hospital ICUs and ICCUs for immediate test results. The i-STAT 1 Analyzer is small, portable, and simple to use. It employs the cutting-edge technology of i-STAT test cartridges. They collaborate to develop the i-STAT system, a point-of-care testing platform that offers diagnostic information to healthcare practitioners when and when it is required. The company distributes i-STAT 1 blood analyzers to numerous distributors around the country. These distributors provide the same to a variety of government and private hospitals in their jurisdiction. The firm, Indian multinational, intends to swiftly grow to all four main metropolises within the next 12 to 24 months.
GENPHARMASEC share price target 2022, 2023, 2024, 2025
Type: Common Stock
Country Name: India
Last Split Factor: 10:1
Last Split Date: 2019-04-11
Generic Pharmasec share price forecast
It is a pharmaceutical stock with a solid track record in the past. Companies in the pharmaceutical sector conduct research, develop, manufacture, and distribute pharmaceuticals and treatments used to treat or eradicate diseases, as well as vaccinate people.. A number of pharmaceutical companies, notably Pfizer, have witnessed an increase in sales after receiving permission from the US and other governments for COVID-19 viral vaccines. The demand for medicine has increased due to COVID-19 and the price rise of medicine, helping the industry.
Gen pharma Target
|MARKET CAP ( CR) ||264|
|EPS –||TTM () [S] 0.07 P/E RATIO (X) [S] 136.00|
|FACE VALUE||() 1|
|LATEST DIVIDEND (%) –|
LATEST DIVIDEND DATE –
DIVIDEND YIELD (%) 0.00
BOOK VALUE / SHARE () [S] 0.64 P/B RATIO
|() [S] 14.88|
|Particulars (Cr)||SEP 2021||SEP 2020||% CHG|
|2024||31-36 ( if covid will be there then it will be 38-40)|